Future Considerations for HIV-1 Protease Inhibitors

Carlson, G. F., Wang, Y., Brewer, J. E., Daenzer, C. L., Baldwin, J. R., and Li, H. (1997). 37th Interscience Conference on Antimicrobial Agents and Chemotherapy Meeting, Toronto. 

Centers for Disease Control (CDC) (1981). MMWRMorb. Mortal. Wkly. Rep. 30, 250-252. Centers for Disease Control (1998). HIV/AIDS Surveillance Report 10, 126-131. 

Farthing, C., Japour, A., Cohen, C., Cameron, W., Follansbee, S., Markowitz, M., Mellors, 

Fischl, M. A., Richman, D. D., Flexner, C., Para, M. F., Haubrich, R., Karim, A.,Yeramian, P., Holden-Wiltse, J., and Meehan, P. M. (1997)./. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 15, 28-34. 

Gallant, J. E., Heath-Chiozzi, M., Raines, C., Anderson, R., Katz, T. K., Fields, C., Jackson, J. B., and Flexner, C. (1998). 5th Conference on Retroviruses and Opportunistic Infections, Chicago, A-394a. 

---